Evidence map›Paper›PMID 12038584›Full record

ArticleJournal of muscle research and cell motility2001

Vectorial phosphorylation of filamentous smooth muscle myosin by calmodulin and myosin light chain kinase complex.

A Sobieszek

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of muscle research and cell motility, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

A SobieszekInstitute of Molecular Biology, Austrian Academy of Sciences, Salzburg. asobieszek@imb.oeaw.ac.at
Austrian Academy of Sciences · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vertebrate smooth muscle myosin extracted from myofibrils and isolated via filament assembly was co-purified with calmodulin (CaM) and myosin light chain kinase (MLCK) which are tightly associated with the filament architecture and, therefore, it may be considered as a native-like preparation. These endogenous contaminates also co-precipitated with a native-like actomyosin, for both cases, at levels sufficient to fully phosphorylate myosin within 10-20 s after addition of ATP and calcium, although their molar ratio to myosin was only about 1 to 100. Phosphorylation progress curves obtained from mixtures of the native-like, and CaM- and MLCK-free filaments indicated that the CaM/MLCK complex preferentially phosphorylated its parent filaments and, as result, the whole myosin present was not maximally phosphorylated. Solubilization of the filaments' mixtures at high ionic strength resulted in slower phosphorylation rates but with maximal phosphorylation levels being attainable. Similar observations were made on the filamentous myosin system reconstituted from the kinase- and CaM-free myosin with added purified MLCK and CaM as well as on the native-like myosin from which only one of these endogenous contaminates was removed by affinity chromatography. These data indicated that not only the MLCK but also CaM was necessary for the observed preferential phosphorylation kinetics. Thus, the native-like filamentous myosin appeared to be phosphorylated by some kind of vectorial mechanism. Similar experiments were carried out on the native-like actomyosin where these vectorial effects were even more pronounced.

Indexed as

Actin CytoskeletonAnimalsCalmodulinMuscle, SmoothMyosin-Light-Chain KinaseMyosinsPhosphorylationTurkeysCalmodulinMyosin-Light-Chain KinaseMyosins

Identifiers

PMID12038584
OpenAlexW232802517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.